Therapeutic intervention

Government pledges to provide legal guidance on 24/7 palliative care

The government said it was “committed” to publishing a modern services framework on palliative care provision to improve access, quality and sustainability of all-age palliative care.…

Minimum age set for puberty blockers trial

To participate in the ‘PATHWAYS’ clinical trial, a modified protocol has ruled that birth-registered females must be aged between 11 and 16 years, and birth-registered males must be aged between 12 and 16 years.…

Why a research mindset matters in critical care pharmacy and beyond

The Royal College of Pharmacy’s chief scientist reports back on a conversation with Cathrine McKenzie, professor of intensive care pharmacy at the University of Southampton, about the contribution that practising pharmacists can make to research.…

Community pharmacy delivers more than 4.5 million flu vaccines in 2025/2026

NHS Business Services Authority data reveals that during the 2025/2026 flu season, the Midlands region delivered the most vaccinations through community pharmacy in England, with more than 860,000.…

Two deaths linked to 2026 measles outbreaks

The UKHSA said one child died from "acute measles" and another child's death was linked to the "late effects of measles".…

NHS England commissions community pharmacies to deliver MenB vaccines to young people

Eligible students will be offered the first dose of a two-dose meningococcal B disease vaccine from July 2026, with a second dose in August 2026.…

Health news round-up: elecoglipron, antibiotic resistant E. coli and low blood pressure risk in frailty

The Pharmaceutical Journal’s weekly summary of the important developments in pharmacy and health news you may have missed.…

The impact of pharmacist-led medication intervention on patient perception and satisfaction following new acute coronary syndrome diagnosis prior to hospital discharge

Cardiovascular disease is a major cause of morbidity and mortality, with acute coronary syndrome (ACS) remaining the leading cause of hospital admissions in the UK​1,2​. Strict adherence to the national guideline directed pharmacotherapy for secondary prevention of ACS is vital to improve patien…

First health security risk assessment highlights risk of respiratory pandemic and AMR

The UK Health Security Agency said that the risk of respiratory infections with pandemic potential was ranked the highest owing to “high impact and likelihood, and repeated historical precedence”.…

NICE approves atogepant for use during migraine attack

Atogepant has been approved for patients who have tried at least two triptans, non-steroidal anti-inflammatory drugs and paracetamol for acute migraines, but they did not work well enough.…